Loading…
Klebsiella pneumoniae Reduces SUMOylation To Limit Host Defense Responses
Klebsiella pneumoniae has been singled out as an urgent threat to human health due to the increasing isolation of strains resistant to “last-line” antimicrobials, narrowing the treatment options against Klebsiella infections. Unfortunately, at present, we cannot identify candidate compounds in late-...
Saved in:
Published in: | mBio 2020-09, Vol.11 (5) |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Klebsiella pneumoniae
has been singled out as an urgent threat to human health due to the increasing isolation of strains resistant to “last-line” antimicrobials, narrowing the treatment options against
Klebsiella
infections. Unfortunately, at present, we cannot identify candidate compounds in late-stage development for treatment of multidrug-resistant
Klebsiella
infections; this pathogen is exemplary of the mismatch between unmet medical needs and the current antimicrobial research and development pipeline. Furthermore, there is still limited evidence on
K. pneumoniae
pathogenesis at the molecular and cellular levels in the context of the interactions between bacterial pathogens and their hosts. In this research, we have uncovered a sophisticated strategy employed by
Klebsiella
to subvert the activation of immune defenses by controlling the modification of proteins. Our research may open opportunities to develop new therapeutics based on counteracting this
Klebsiella-
controlled immune evasion strategy.
Klebsiella pneumoniae
is an important cause of multidrug-resistant infections worldwide. Understanding the virulence mechanisms of
K. pneumoniae
is a priority and timely to design new therapeutics. Here, we demonstrate that
K. pneumoniae
limits the SUMOylation of host proteins in epithelial cells and macrophages (mouse and human) to subvert cell innate immunity. Mechanistically, in lung epithelial cells,
Klebsiella
increases the levels of the deSUMOylase SENP2 in the cytosol by affecting its K48 ubiquitylation and its subsequent degradation by the ubiquitin proteasome. This is dependent on
Klebsiella
preventing the NEDDylation of the Cullin-1 subunit of the ubiquitin ligase complex E3-SCF-βTrCP by exploiting the CSN5 deNEDDylase.
Klebsiella
induces the expression of CSN5 in an epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT)-extracellular signal-regulated kinase (ERK)-glycogen synthase kinase 3 beta (GSK3β) signaling pathway-dependent manner. In macrophages, Toll-like receptor 4 (TLR4)-TRAM-TRIF-induced type I interferon (IFN) via IFN receptor 1 (IFNAR1)-controlled signaling mediates
Klebsiella
-triggered decrease in the levels of SUMOylation via
let-7
microRNAs (miRNAs). Our results revealed the crucial role played by
Klebsiella
polysaccharides, the capsule, and the lipopolysaccharide (LPS) O-polysaccharide, to decrease the levels of SUMO-conjugated proteins in epithelial cells and macrophages. A
Klebsiel |
---|---|
ISSN: | 2161-2129 2150-7511 |
DOI: | 10.1128/mBio.01733-20 |